The regulatory role of AT1 receptor on activated HSCs in hepatic fibrogenesis: Effects of RAS inhibitors on hepatic fibrosis induced by CCl4

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 6, Issue 6

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

307

HTML

2090

Figures (1-3)

139

Tables (1-3)

142

Sum=2678

Dec 15, 2000 (publication date) through Jul 28, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Articles

World J Gastroenterol. Dec 15, 2000; 6(6): 824-828
Published online Dec 15, 2000. doi: 10.3748/wjg.v6.i6.824

Table 3 Fibrosis measurements

	Control	Model	Enalapril	Losartan	Enalapril+losartan
Area of fibrosis	0.94 ± 0.33	11.22 ± 4.79^a	5.38 ± 3.43^b	4.96 ± 2.96^b	4.23 ± 3.70^b

^aP < 0.01 vs Control;

^bP < 0.05 vs Model.

Citation: Wei HS, Lu HM, Li DG, Zhan YT, Wang ZR, Huang X, Cheng JL, Xu QF. The regulatory role of AT1 receptor on activated HSCs in hepatic fibrogenesis: Effects of RAS inhibitors on hepatic fibrosis induced by CCl₄. World J Gastroenterol 2000; 6(6): 824-828
URL: https://www.wjgnet.com/1007-9327/full/v6/i6/824.htm
DOI: https://dx.doi.org/10.3748/wjg.v6.i6.824